Sexual Functioning and Quality of Life Among Women With Endometriosis: A French Cross-Sectional Survey

Dyspareunia was the dominant sexual dysfunction in 1,586 French endometriosis patients; the QoL-sex link disappeared in obese and low-education subgroups

Journal: Perspectives on Sexual and Reproductive Health | Published: 2025-12-03 | Type: Cross-sectional survey | PMID: 41340434 Authors: Vallée A, Arutkin M, Ceccaldi P-F, Horsman S, Ayoubi J-M (Foch Hospital, Suresnes, France) Funding/COI: Not reported

Summary

An anonymous online survey of 1,586 French women with endometriosis found a statistically significant but clinically thin association between sexual functioning (measured by FSFI) and quality of life. Dyspareunia emerged as the dominant driver of sexual dysfunction in this population. The association between sexual function and QoL disappeared entirely in obese women and those with low educational attainment — a finding the authors flag but don't adequately explain.

Claims

• Overall FSFI score associated with QoL: OR = 1.02 (95% CI 1.01–1.04), p = 0.002
• In moderate-education subgroup, the association strengthened: OR = 1.07 (95% CI 1.04–1.10), p < 0.001
• In moderate-BMI subgroup: OR = 1.05 (95% CI 1.02–1.08), p = 0.002
• No statistically significant association found between sexual function and QoL in obese women or those with low educational level
• Dyspareunia ranked as the most strongly associated FSFI component (FDR logworth = 9.1, p < 0.001)

Study Quality

This is a cross-sectional online survey — the weakest study design for causal inference. The 1,586-person sample is substantial for this type of research, and the authors applied multivariable logistic regression adjusting for age, BMI, tobacco use, education, parity, symptom count, and menopause status. Interaction analyses to identify subgroup effects are methodologically appropriate. The FDR (false discovery rate) correction in the logworth analyses is a reasonable attempt to handle multiple comparisons.

However, the headline OR of 1.02 deserves scrutiny. A 2% increase in odds per FSFI unit is statistically significant with 1,586 participants but represents a clinically marginal effect. The paper's conclusion — that professionals "must address" sexual dysfunction to ensure QoL — substantially outpaces what a cross-sectional OR of 1.02 can support.

Red Flags

• Design ceiling: Cross-sectional data cannot establish whether sexual dysfunction reduces QoL, or whether poor QoL impairs sexual function — or whether a third variable drives both
• No control group: There are no women without endometriosis for comparison; the survey only captures endometriosis patients
• Self-reported diagnosis: Definitive endometriosis diagnosis requires laparoscopy; the survey relied on self-report, introducing potential misclassification
• Recruitment opacity: How 1,586 respondents were recruited from an anonymous online survey is not described; self-selection bias is a serious concern
• Funding and COI not reported: Neither funding source nor conflicts of interest are declared
• Effect size vs. conclusion mismatch: A primary OR of 1.02 does not justify strong clinical recommendations; the authors overclaim
• French-only sample: Findings may not generalize beyond France

Strengths

• Largest cross-sectional sample on this specific question in a French endometriosis population
• Validated instrument (FSFI) with dimensional subscale analysis
• Appropriate covariate adjustment including BMI, education, parity, and symptom burden
• Subgroup interaction analyses reveal a genuinely interesting pattern (association disappears in obese and low-education groups)
• FDR correction applied to logworth analyses

Verdict

The dyspareunia finding is not new — it's consistent with the existing literature. The subgroup finding (no QoL-sex association in obese or low-education women) is the paper's one genuinely interesting result, and the authors barely engage with it. The primary effect size is so small that the conclusion reads like advocacy dressed in statistics. This paper adds modest confirmation to an established association, not new knowledge. Worth a skim for the subgroup breakdown; don't cite it as evidence that treating sexual dysfunction improves QoL in endometriosis — this study cannot show that.